Field dossier · from the corpus
Ovarian cancer
0predicted collisions
Where this field is predicted to collide
No open collisions on this field in the current run.
Most cited work
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study
Applications of patient-derived tumor xenograft models and tumor organoids